NCT06653777
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06653777
Title Efficacy of Pemigatinib in Patients With Solid Tumors Characterized by an Alteration of the Gene FGFR in Tumor Cells (AcSe PEMI)
Acronym AcSe PEMI
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors UNICANCER
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
CHU de BREST RECRUITING Brest France Details
Centre Antoine Lacassagne ACTIVE_NOT_RECRUITING Nice France Details
Institut Curie NOT_YET_RECRUITING Paris France Details
CHU Poitiers ACTIVE_NOT_RECRUITING Poitiers France Details
CHU Saint Etienne ACTIVE_NOT_RECRUITING Saint-Priest-en-Jarez France Details
Institut de Cancerologie de Lorraine ACTIVE_NOT_RECRUITING Vandœuvre-lès-Nancy 54500 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field